Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials Other Scholarly Work

cited authors

  • Garmendia, Craig A; Gorra, Liliana Nassar; Rodriguez, Ana Lucia; Trepka, Mary Jo; Veledar, Emir; Madhivanan, Purnima

sustainable development goals

authors

publication date

  • April 1, 2019

webpage

published in

keywords

  • General & Internal Medicine
  • Life Sciences & Biomedicine
  • Medicine, General & Internal
  • Science & Technology

WoS ID

  • 000465155100026

Digital Object Identifier (DOI)

start page

  • 582

end page

  • 584

volume

  • 179

issue

  • 4

open access

  • true